Science and Technology Science and Technology
Tue, April 3, 2012

NI Technology Updates Outlooks for Research in Motion, Marvell Technology Group, Cree, GSI Technology, and Cavium


Published on 2012-04-03 06:36:05 - Market Wire
  Print publication without navigation


NI Technology Updates Outlooks for Research in Motion, Marvell Technology Group, Cree,... -- PRINCETON, N.J., April 3, 2012 /PRNewswire/ --

NI Technology Updates Outlooks for Research in Motion, Marvell Technology Group, Cree, GSI Technology, and Cavium

[ ]

PRINCETON, N.J., April 3, 2012 /PRNewswire/ -- Next Inning Technology Research ([ http://www.nextinning.com ]), an online investment newsletter focused on semiconductor and technology stocks, has published updated outlooks for Research in Motion (Nasdaq: [ RIMM ]), Marvell Technology Group (Nasdaq: [ MRVL ]), Cree (Nasdaq: [ CREE ]), GSI Technology (Nasdaq: [ GSIT ]), and Cavium (Nasdaq: CAVM).

Editor Paul McWilliams spent a decades-long career in the technology industry, and has earned a reputation for his skill at communicating complex technology trends to individual investors and professional analysts alike. His reports have won over readers with their ability to unravel the complexities of the industry and, more importantly, identify which companies are likely to be the winners and losers as technology trends change.

The Electronic Manufacturing Services (EMS) sector is where smart investors look to check the pulse of the tech industry.  Over the weekend, Next Inning published its highly acclaimed State of Tech report covering the EMS sector.

This report covers the five largest EMS companies that are traded on U.S. stock exchanges and provides deep insight into the contract manufacturing companies that build everything from iPhones to 4G cellular basestations. In its 20+ pages, it includes 22 tables providing fundamental data and valuation analysis as well as detailed commentary, forecasts and actionable ideas for the various companies that are making headlines today.

To get ahead of the Wall Street curve and receive his latest reports for free, you are invited to take a free, 21-day, no obligation trial with Next Inning.  For full details on this offer, please visit the following link:

[ https://www.nextinning.com/subscribe/index.php?refer=prn1387 ]

McWilliams covers these topics and more in his latest reports:

-- Wall Street pundits are shouting that RIM's most recent earnings report signals the impending demise of the company. Are the analysts and commentators right, or has a big buying opportunity opened up for investors willing to take the other side? What are the challenges still facing RIM, and why might the company's chances appear slightly better now than they did prior to last week's conference call?  Why did McWilliams term that conference call as both the best and worst RIM conference call he can remember?

-- Should investors be tempted by the recent tender offer for shares of Marvell? What do investors need to know about mini-tender offers in general?

-- Does new semiconductor sales data suggest that trends in Cree's key markets are working in the company's favor? In a December 13th, 2011 report McWilliams wrote that Cree had been substantially oversold at its then current price of $22.78, and he reiterated that opinion a month later when Cree was still trading below $25.  With Cree now trading nearly 40% higher from it was in December, does he see further upside for the stock? Could shares move above $40 in the near term?

-- With GSI Technology trading at what appears to be a very low valuation based on its balance sheet value and with the company buying back shares, is it time to consider buying the stock? Does GSI occupy a lucrative niche in the memory market? What sort of competition does the company face?

-- Hours before the market close on Monday, McWilliams alerted Next Inning readers that he thought Cavium would come up light for Q1.  Roughly five hours later, after the closing bell rang, Cavium confirmed his suspicions.  Not only did McWilliams nail the big picture for Cavium, he also got the details right as to what led to Cavium's first quarter weakness.  This is just one of many examples why Next Inning readers stay ahead of Wall Street.

Founded in September 2002, Next Inning's model portfolio has returned 312% since its inception versus 56% for the S&P 500.

About Next Inning:

Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks.  Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926.  Interested parties may visit adviserinfo.sec.gov for additional information.  Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515

SOURCE Indie Research Advisors, LLC

[ Back to top ]

RELATED LINKS
[ http://www.nextinning.com ]

Contributing Sources